Neonatology Flashcards
The effect of neonatal dysphagia on subsequent racing performance in Standardbred horses
•Dysphagia, associated with environmental PAH exposure, does not negatively impact racing performance in foals that survive to training.
•No significant difference in age of first race, Speed Index, or Earnings Per Start Index between dysphagic and healthy foals. Started racing at same time (median 2 years).
•Racing outcomes for dysphagic foals align with general Standardbred statistics (66% of foals born between 2012-2017 raced).
• Treatment of neonatal dysphagia, though costly, is justified given the lack of long-term negative effects on athleticism.
Comparison of the diagnostic predictability of serum amyloid A, white blood cell count and immunoglobulin G tests as indicators of early-onset, acute-phase morbidities in newborn foals
Serum amyloid A (SAA) is identified as a superior biomarker for detecting early-onset, acute-phase infections and inflammatory conditions in newborn foals compared to WBC count and IgG levels in foals <36hours old.
At a positivity threshold of 100 mg/L, SAA showed:
• Sensitivity: 41.7%
• Specificity: 94.7%
• Positive Predictive Value (PPV): 55.6%
• Negative Predictive Value (NPV): 91.1%
• SAA’s accuracy (87.4%) was higher than both WBC (73.1%) and IgG (81.7%).
SAA Testing:
• Detects inflammation rapidly due to its dynamic response.
• Elevated levels correlate with both infectious and non-infectious inflammatory conditions.
• Useful in identifying subclinical infections before clinical signs emerge.
• SAA testing combined with WBC count improved diagnostic accuracy and PPV to 66.7%.
• Limitations: False negatives: Some sick foals showed SAA levels below the positivity threshold (14 out of 24 nonhealthy foals). False positives: A few healthy foals had elevated SAA values, likely due to noninfectious inflammation or early-stage infection.
Serum Amyloid A in Diagnosing Sepsis in Equine Neonates
Median SAA in septic foals: 114 µg/mL. Significantly greater than for other groups.
- For healthy vs septic: At diagnostic threshold of 100ug/ml, Sensitivity: 52.9%, specificity: 97.5%. High specificity but moderate sensitivity. PPV 75%, NPV 93.7%. AUC ROC curve 0.806
-could not distinguish healthy from SNS
-serial measurements may improve Se
Diagnostic characteristics of refractometry cut-off points for estimating immunoglobulin G concentration in mare colostrum
•Both optical (OR) and digital refractometers (DR) were validated as effective tools for assessing colostrum quality by estimating immunoglobulin G (IgG) concentrations.
Optimal Cut-off Points: align closely with previous studies and indicate poor colostrum quality (<60 g/L IgG).
• DR: ≤23.75%
• OR: ≤23.90%
Digital Refractometer (DR): Sensitivity: 93.3% Specificity: 87.9% Positive Predictive Value (PPV): 63.6% Negative Predictive Value (NPV): 98.3%
Optical Refractometer (OR): Sensitivity: 93.3% Specificity: 81.8% PPV: 53.8% NPV: 98.2%
• Both refractometers demonstrated high accuracy, particularly in ruling out poor-quality colostrum due to high NPV values.
• Strong correlation observed between IgG concentrations measured by RID and refractometers for both Dr and OR
• High correlation between DR and OR readings ( =0.992), confirming interchangeability for colostrum assessment.
• Moderate correlation between serum and colostrum IgG concentrations (=0.542), supporting colostrum evaluation as an indirect predictor of neonatal immunity.
Use in combination with serum IgG measurement
Comparative evaluation of clinical findings and prognostic outcome parameters in hospitalized, critically ill neonatal foals and crias
Foals: septic arthritis (11.8%), omphalitis (14.6%), and patent urachus (10.4%). Gastrointestinal diseases, including diarrhea (33.4%) and colic/constipation (13.2%), significantly more common.
Both species showed similar rates of lower respiratory disease (~32%).
Lower prevalence congential abnormalities (7.3%), with umbilical/inguinal hernias and skeletal deformities as most common defects. Only 23% of defects considered fatal.
SEPSISPED: Better predictor of mortality in both species compared to SEPSISNEO.
SEPSISNEO: Hyperlactatemia and hypoglycemia associated with foal mortality, not crias.
Shared Mortality Predictors:
Lower respiratory disease significantly increases mortality in both species (4.4–4.8-fold).
Oxygen therapy and glucose supplementation correlate with disease severity and poor outcomes.
Foal-Specific Predictors: Septic arthritis and omphalitis. Dysregulated glucose and lactate metabolism.
survival to discharge: foals 82.1%.
Assessment of the immunocrit method to detect failure of passive immunity in newborn foals
• Demonstrated strong correlation (R = 0.871) with agarose gel electrophoresis (AGE), a gold standard for measuring serum immunoglobulin levels.
• Reliable cut-off established: Immunocrit: ≥9.5% AGE: ≥8 g/L
• Sensitivity: 94% Specificity: 82% NPV: 84.74% PPV: 92.76%
• Quick, quantitative, and inexpensive compared to traditional methods.
• Requires minimal equipment, making it accessible for on-farm diagnostics.
• Small sample volume (70 µL) and rapid processing time (6-7 minutes) enhance practicality. Does not differentiate types on immunoglobulin
Advantages of the Immunocrit Method
Area Under the Curve (AUC): 93.7% Indicates high diagnostic utility for detecting FPT.
Repeatability: Excellent agreement within triplicate measurements (Cohen’s Kappa = 0.92).
Accessibility: Ideal for field use in horse farms with limited access to sophisticated laboratory facilities.
Normal regression of the internal umbilical remnant structures in Standardbred foals
• Rapid, linear regression of the umbilical vein, arteries, and urachus occurs over the first 5-6 weeks of life in Standardbred foals.
• The largest measurements were at 24 hours of age with a median umbilical vein diameter of 0.83 cm, median umbilical artery diameter of 0.61 cm and median urachal diameter of 1.07 cm.
• By 5-6 weeks, umbilical remnants, especially the arteries, become difficult to identify via ultrasonography.
•Median diameters of all structures significantly decrease: 16%-22% reduction within the first week of life. 66%-75% reduction by 6 weeks of age.
• Umbilical vein remained more identifiable compared to arteries as foals aged.
• Urachus often collapsed early, becoming a potential space rather than a fluid-filled lumen.
• Previously reported “normal” measurements did not consider foal age and might misguide clinical interpretations-> should use age adjusted ref values for more accurate identification of early pathology
Transfusion with 2 litres of hyperimmune plasma is superior to transfusion of 1 litre for protecting foals against pneumonia attributed to Rhodococcus equi
• Retrospective cohort- propective study coming
• Transfusing 2 liters of hyperimmune plasma (REHIP) to foals significantly reduced the odds of pneumonia attributed to Rhodococcus equi (R. equi) compared to 1 liter.
• Odds of pneumonia were 2.4 times greater in foals receiving 1 liter (95% CI: 1.1–5.6; P = 0.0457).
• Findings align with prior studies indicating that antibody-mediated immunity offers protection against R. equi.
• Foals born in April and May had a 2.7-fold increased risk of developing pneumonia compared to those born earlier (January–March) (95% CI: 1.3–5.4; P = 0.0064).
• No adverse reactions to transfusions of 2 liters of plasma were observed
• variability in farm management practices, environment, or density as contributing factors.
• original study, used pony foals each of which weighed approximately 25 kg corresponding to a plasma dose of approximately 40 mL/kg. Since most horse foals weigh approximately 50-kg, 1 L of plasma represents a dose of REHIP of roughly 20 mL/kg of body weight.
Nasal high flow oxygen therapy in hospitalised neonatal foals
• HFOT was successfully implemented using modified human systems, providing heated and humidified oxygen. Used in 14 foals, 10 survived to dischagre. Median duration 43 hours.
• Clinical improvements, including better respiratory patterns and reduced respiratory effort, were observed in most foals.
• Although improvements in oxygenation (PaO2) and carbon dioxide clearance (PaCO2) were noted, they were not statistically significant.
• No significant complications were associated with HFOT.
Indications for Use:
• HFOT is recommended for foals with worsening respiratory function despite TOT.
• Effective in cases where preventing atelectasis or providing additional respiratory support is necessary.
• HFOT avoids the complications and technical demands of mechanical ventilation.
• Compared to CPAP, HFOT is easier to implement and better tolerated, as it does not require a tight nasal seal.
• Unlike initial CPAP studies in foals, HFOT did not lead to hypercapnia.
Respiratory Support:
• Mechanisms of HFOT effectiveness include reduced airway resistance, enhanced dead space washout, and low positive airway pressure.
• Flow rates of 0.7 L/kg/min in foals align with effective rates used in humans for maintaining positive airway pressure.
A target starting respiratory gas flow rate of 40 L/min was used based on recommendations from human use. Specific FiO2 not targeted.The 40 L/min target could not be achieved when using 20 FR chest tubes and the maximum total flow rate was limited to between 25 and 35 L/min. the size of the nasal tubes was assessed to ensure that they did not obstruct more than 50% of the nasal diameter
Red cell distribution width values and red cell distribution width-to-platelet ratio in Thoroughbred foals in the first 24 hours of life
• RPR was significantly higher in at-risk foals (0.073 ± 0.018) compared to healthy foals (0.068 ± 0.014, P = 0.01). Suggests RPR as a potential biomarker for identifying neonatal foals at risk of systemic disease.
• RDW values were not significantly different between healthy and at-risk foals. Negative correlation with gestational age (r = –0.156, P = 0.005), linking RDW to foal maturity.
• Elevated RPR reflects an imbalance in the proportion of RDW to platelet count, potentially linked to inflammatory responses and early systemic disorders.
• The correlation between RDW and gestational age suggests its utility in assessing neonatal maturity and potential vulnerabilities.
Requires validation for actually sick foals and on different farms
• Increased RDW may result from inflammatory mediators (e.g., tumor necrosis factor, interleukin-6) suppressing erythropoiesis and reducing red blood cell (RBC) maturation. Acute hypoxic events and systemic inflammation can increase RDW variability.
Differences in isolation rate and antimicrobial susceptibility of bacteria isolated from foals with sepsis at admission and after ≥48 hours of hospitalization
Hospital-acquired pathogens (Acinetobacter spp., Enterococcus spp., Klebsiella spp., Pseudomonas spp., Serratia spp.) showed significantly higher odds of being isolated:
• Acinetobacter spp.: Odds ratio (OR) 7.63 (95% CI: 1.28–45.45).
• Enterococcus spp.: OR 5.37 (95% CI: 2.64–10.90).
• Klebsiella spp.: OR 2.27 (95% CI: 1.05–4.89).
• Pseudomonas spp.: OR 3.49 (95% CI: 3.49–240.50).
• Serratia spp.: OR 20.23 (95% CI: 2.20–186.14).
Decreased Isolation:
• Bacteria susceptible to initial antimicrobial treatment, such as Actinobacillus spp. (OR 0.15, 95% CI: 0.00–0.91) and Streptococcus spp. (OR 0.35, 95% CI: 0.13–0.91), were less frequently isolated after 48 hours.
•Escherichia coli remained the most frequently isolated bacterium at both time points, although its susceptibility to antimicrobials decreased over time.
Resistance Trends:
• Bacteria isolated after ≥48 hours were significantly less susceptible to all tested antimicrobials except for imipenem:
• Amikacin: Susceptibility dropped from 68.6% at admission to 42.4% after 48 hours.
• Ceftiofur: Susceptibility dropped from 90.9% to 49.4%.
• Gentamicin: Susceptibility dropped from 68.6% to 30.6%.
• Imipenem maintained relatively high efficacy (94.1% vs. 77.6%, OR 0.49, 95% CI: 0.18–1.33).
• Resistance patterns were unpredictable, complicating empirical treatment decisions.
• Even within E. coli, susceptibility decreased significantly for most drugs, suggesting selection of resistant strains and development of acquired resistance during hospitalization.
Of 82 isolates collected after ≥48 hours:
• 85.4% (n = 70) were not isolated at admission, suggesting potential hospital-acquired infections (HAIs).
• 6.1% (n = 5) were isolated at both time points and remained susceptible to the initial treatment, indicating treatment failure.
• 4.9% (n = 4) were initially susceptible but became resistant, suggesting acquired resistance during hospitalization.
• 3.7% (n = 3) were resistant at both time points.
• HAIs are likely a significant source of sepsis in hospitalized foals. Bacteria commonly associated with HAIs in human and veterinary medicine (Enterococcus spp., Klebsiella spp., Pseudomonas spp., Acinetobacter spp.) were frequently isolated after 48 hours.
• Controlling HAIs is critical to reducing morbidity and mortality in neonatal intensive care units (NICUs).
• Initial empirical regimens are appropriate at admission but become less effective over time due to resistance development.
• Empirical treatment should be adjusted promptly based on susceptibility testing of new isolates collected during hospitalization.
• Imipenem and other critically important antimicrobials should be reserved for cases with no other effective options, following World Health Organization (WHO) guidelines.
•The unpredictable resistance patterns observed in this study highlight the limitations of relying solely on admission culture results to guide therapy for ongoing infections
Considering that results of culture and antimicrobial susceptibility testing typically are not available for at least 48 hours after sample collection, it would be rational to repeat bacteriological culture and susceptibility testing at 48 hours intervals on foals hospitalized in
neonatal intensive care units, in order to detect on-going infections or HAIs at an early stage and select effective antimicrobials for treatment.
Plasma iron concentrations and systemic inflammatory response syndrome in neonatal foals
• Plasma iron concentrations showed large variability among healthy neonatal foals, with a wider range (58.8–305 µg/dL) than previously reported in adult horses (105–277 µg/dL).
• This variability was particularly evident in the first 3 days of life, reflecting rapid changes in iron metabolism during early neonatal adaptation.
• No significant difference in plasma iron concentration was observed between foals with systemic inflammatory response syndrome (SIRS) and non-SIRS foals. Or outcome
• Plasma iron concentration negatively correlated with age in sick foals (r = –0.598) and healthy hospitalized foals (r = –0.387). Concentrations were higher in younger foals and declined with age during the first two weeks of life.
• Healthy foals from the hospital had significantly lower plasma iron concentrations (126.1 µg/dL) than those from the stud farm (181.8 µg/dL). This difference may reflect varying maternal conditions, colostrum/milk intake, or environmental factors, compounded by the age differences between these groups.
• Iron concentrations in healthy foals rise rapidly after birth due to colostrum absorption and subsequently decrease, mirroring patterns seen in human neonates. The initial rise in plasma iron supports erythropoiesis, while subsequent declines may be driven by hemoglobin catabolism and shifts in oxygen demand post-birth.
• Mechanisms such as hepcidin-mediated iron sequestration, which play a role in adult inflammation, might not function identically in neonatal foals.
• Interpretation of plasma iron values in foals requires age-specific reference ranges due to significant age-related changes in concentration during the neonatal period.
Oxidative state in equine neonates: Anti- and pro-oxidants
• TBARS (a lipid peroxidation marker) levels were highest at 5 minutes post-birth and decreased significantly at 72 and 168 hours postpartum. Indicates high reactive oxygen species (ROS) production at birth, related to neonatal adaptation processes like pulmonary expansion and oxygen exposure.
Antioxidant Systems:
• Unconjugated Bilirubin (UB): Levels increased at 12 hours postpartum and decreased by 72 hours, stabilizing by 168 hours. Negative correlation between UB and TBARS suggests UB’s protective role against lipid peroxidation.
• Glutathione Peroxidase (GPx): Activity increased at 12 and 72 hours compared to immediately after birth, complementing UB’s role in ROS neutralization. GPx showed a negative correlation with TBARS and positive correlations with UB and TB, indicating a coordinated antioxidative mechanism.
• Superoxide Dismutase (SOD): Activity remained constant throughout the first week of life, suggesting SOD was not the primary mechanism for managing oxidative stress during this period.
•High lipid peroxidation shortly after birth reflects the stress of transitioning from fetal to neonatal life. Antioxidant systems, particularly UB and GPx, are crucial in maintaining oxidative homeostasis and protecting against ROS damage.
Hanoverian F/W-line contributes to segregation of Warmblood fragile foal syndrome type 1 variant
• The PLOD1:c.2032G>A mutation was confirmed as the causative variant for Warmblood Fragile Foal Syndrome Type 1 (WFFST1).
• The mutant allele was identified at a frequency of 14% in Hanoverian horses, higher than previously reported in other Warmblood populations (5.5% in Brazil).
•Affected foals exhibited severe connective tissue abnormalities, including fragile skin, subcutaneous emphysema, and joint hyperextension.
• Histopathology revealed: Loosely arranged, thinned collagen fibers in the dermis.
• Electron microscopy showed irregularly shaped, swollen collagen fibrils and fibrillar plaques interspersed in an amorphous matrix.
Association with Performance Traits:
• Significant correlations were observed between WFFST1 carrier status and positive breeding values (EBVs) for traits like gait quality, elasticity, and dressage performance.
• No significant associations were found with embryonic loss or stallion fertility, suggesting that losses in homozygous foals occur during late gestation or at birth, not during early embryonic development.
Pedigree and Origin Analysis:
• Pedigree tracing identified Stallion A (1861 Hanoverian F/W line) as the most recent common ancestor (MRCA) for all 81 tested genetic carriers.
• The WFFST1 mutation likely originated in Thoroughbreds, which contributed 34.8% of the Hanoverian genetic pool (1980-2000).
Biological Implications
• The PLOD1 mutation disrupts lysyl hydroxylase activity, critical for collagen cross-linking and stability.
• Variations in collagen expression between tissues may explain phenotypic differences among affected foals and carrier horses.
•The mutation’s widespread prevalence in Warmblood horses reflects both historical gene flow and the selective use of carriers in dressage-focused breeding programs.
• Positive selection for gait and conformation traits likely facilitated the mutation’s propagation.
Retrospective evaluation of the association between hyponatremia and neurological dysfunction in hospitalized foals: 109 cases